HI
AMRX icon

Harbour Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Harbour Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 2644
2021
Q3 		$1K Hold
100
– – ﹤0.01% 3427
2021
Q2 		$1K Hold
100
– – ﹤0.01% 3486
2021
Q1 		$1K Buy
+100
New +$554 ﹤0.01% 3319

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Harbour Investments's AMRX Position: Q4 2021 in Review

Harbour Investments sold out of Amneal Pharmaceuticals (AMRX) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Harbour Investments first reported a position in AMRX in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 154 funds tracked by Wall St. Rank hold AMRX as of Q4 2021.

  • Harbour Investments reported no remaining Amneal Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Harbour Investments sold 100 Amneal Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Harbour Investments first reported a position in Amneal Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Harbour Investments's Amneal Pharmaceuticals position peaked at $1K in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.